HTI
Showing 1 - 25 of 25
Healthy Trial in Oxford (ChAdOx1.HTI and MVA.HTI)
Completed
- Healthy
- ChAdOx1.HTI and MVA.HTI
-
Oxford, United KingdomCentre for Clinical Vaccinology and Tropical Medicine, Churchill
Aug 31, 2022
HIV Infection Trial in Badalona (ChAdOx1.HTI at week 0, ConM SOSIP.v7 at weeks 4, 12 and 28, and MVA.HTI at week 22 (CSSMS).,
Recruiting
- HIV Infection
- ChAdOx1.HTI at week 0, ConM SOSIP.v7 at weeks 4, 12 and 28, and MVA.HTI at week 22 (CSSMS).
- Normal saline solution
-
Badalona, Barcelona, SpainGermans Trias i Pujol Hospital
Jul 11, 2022
Neuroendocrine Carcinoma of the Bladder, Bladder Cancer Trial (Adebrelimab, Etoposide, Cisplatin)
Not yet recruiting
- Neuroendocrine Carcinoma of the Bladder
- Bladder Cancer
- Adebrelimab
- +3 more
- (no location specified)
Oct 14, 2023
HIV/AIDS Trial in Spain (ChAdOx1.HTI, MVA.HTI, GS-9620)
Active, not recruiting
- HIV/AIDS
- ChAdOx1.HTI
- +4 more
-
Badalona, Barcelona, Spain
- +8 more
Jul 30, 2021
HIV Trial in Badalona (DNA.HTI 0.5mL at weeks 0, 4 and 8 + MVA.HTI 0.5mL at weeks 12 and 20 (DDDMM), At least 24 weeks since
Completed
- HIV
- DNA.HTI 0.5mL at weeks 0, 4 and 8 + MVA.HTI 0.5mL at weeks 12 and 20 (DDDMM)
- +2 more
-
Badalona, Barcelona, SpainIrsiCaixa AIDS Research Institute, Hospital Universitari Germans
Apr 7, 2021
Advanced Solid Tumors Trial in Perth (SHR-1316)
Completed
- Advanced Solid Tumors
-
Perth, West Australia, AustraliaLinear Clinical Research
Jul 11, 2022
Hemophilia A Trial in United States (Nuwiq (low dose protocol), HEMLIBRA, Nuwiq (Atlanta protocol))
Recruiting
- Hemophilia A
- Nuwiq (low dose protocol)
- +2 more
-
Los Angeles, California
- +7 more
Feb 21, 2022
Plantar Fascitis Trial in Nantes (Percutaneous tenotomy + PRP)
Not yet recruiting
- Plantar Fascitis
- Percutaneous tenotomy + PRP
-
Nantes, FranceCHU de Nantes
Nov 13, 2022
Intervertebral Disc Herniation Trial in Moscow, Novosibirsk (Preoperative risk estimation of disc herniation recurrence)
Recruiting
- Intervertebral Disc Herniation
- Preoperative risk estimation of disc herniation recurrence
-
Moscow, Russian Federation
- +1 more
Apr 5, 2022
Objective Instrument to Measure Hot Flashes During Menopause
Terminated
- Menopause
- Hot Flashes
- iButton®
-
Baton Rouge, LouisianaPennington Biomedical Research Center
Jan 31, 2023
Lumbar Spinal Stenosis, Intervertebral Disc Degeneration Trial in Moscow (lumbar fusion)
Recruiting
- Lumbar Spinal Stenosis
- Intervertebral Disc Degeneration
- lumbar fusion
-
Moscow, Russian FederationPriorov National Medical Research Center of Traumatology and Ort
Jan 21, 2022
HDL Trial in Nashville (CardioLux™HDL, Placebo)
Active, not recruiting
- HDL
- CardioLux™HDL
- Placebo
-
Nashville, TennesseeHypertension Institute
Apr 4, 2022
Superb Microvascular Imaging Ultrasonography of Plantar
Recruiting
- Diagnose Disease
- Plantar Fasciitis
- Superb Microvascular Imaging (SMI) (Toshiba)
-
Niğde, TurkeyNigde Omer Halisdemir University
Aug 3, 2021
Advanced Solid Tumor Trial in Shanghai (SHR-A1403)
Unknown status
- Advanced Solid Tumor
-
Shanghai, ChinaShanghai Cancer Center, Fudan University
Feb 26, 2019
Intervertebral Disc Degeneration, Lumbar Spinal Stenosis Trial in Novosibirsk (Lumbar fusion)
Withdrawn
- Intervertebral Disc Degeneration
- Lumbar Spinal Stenosis
- Lumbar fusion
-
Novosibirsk, Russian FederationNovosibirsk Research Institute of Traumatology and Orthopaedics
Sep 9, 2020
Empowerment Trial in Zaria, Kalgo (Girls for Health)
Withdrawn
- Empowerment
- Girls for Health
-
Zaria, Kaduna, Nigeria
- +1 more
Aug 8, 2019
Solid Tumor, Adult Trial in Scottsdale, Nashville, Houston (HTI-1066 dose level 1, HTI-1066 dose level 2, HTI-1066 dose level 3)
Unknown status
- Solid Tumor, Adult
- HTI-1066 dose level 1
- +3 more
-
Scottsdale, Arizona
- +2 more
Jan 6, 2018
Coronary Artery Disease Trial in Nashville (FMD Arm)
Completed
- Coronary Artery Disease
- FMD Arm
-
Nashville, TennesseeHypertension Institute
Jul 30, 2020
Causes of Peripheral Hypotonia in Assiut University Children
Unknown status
- Infant Floppy
- (no location specified)
Feb 26, 2019
HIV 1 Infection Trial in Pittsburgh (Dapivirine gel (0.05%), Universal HEC gel)
Withdrawn
- HIV 1 Infection
- Dapivirine gel (0.05%)
- Universal HEC placebo gel
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center
Feb 6, 2017
Smoking Trial in Västerås (Nix Individual, Fimpa dig fri)
Completed
- Smoking
- Nix Individual
- Fimpa dig fri
-
Västerås, SwedenCentre for clinical research, Central Hospital
Apr 30, 2008